Joanna Szarmach

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 6

Top Topics

Major Depressive Disorder

Multidrug Resistant

Top Venues

Journal of clinical medicine

Psychiatry and clinical psychopharmacology

Neuropsychiatric disease and treatment

Medicina (Kaunas, Lithuania)

This page only lists publications with an associated author ORCID identifier.

Publications

Agata Maria Grzegorzewska, Mariusz Stanisław Wiglusz, Katarzyna Jakuszkowiak-Wojten, Wiesław Jerzy Cubała, Adam Wlodarczyk, Joanna Szarmach
Interictal Dysphoric Disorder in Epilepsy and Its Relationship with Specific Clinical and Demographic Variables. Psychiatry and clinical psychopharmacology 34 (2) (2024)
Agata Maria Grzegorzewska, Mariusz Stanisław Wiglusz, Katarzyna Jakuszkowiak-Wojten, Wiesław Jerzy Cubała, Adam Wlodarczyk, Joanna Szarmach
Interictal Dysphoric Disorder in Epilepsy and Its Relationship with Specific Clinical and Demographic Variables. Psychiatry and clinical psychopharmacology 34 (2) (2024)
Agata M Grzegorzewska, Mariusz S Wiglusz, Wiesław Jerzy Cubała, Katarzyna Jakuszkowiak-Wojten, Adam Wlodarczyk, Joanna Szarmach
Dysphoria and Irritability-Diagnostic Pitfalls in the Assessment of Interictal Dysphoric Disorder in Epilepsy. Journal of clinical medicine 10 (19) (2021)
Agata Maria Grzegorzewska, Mariusz Stanisław Wiglusz, Jerzy Landowski, Katarzyna Jakuszkowiak-Wojten, Wiesław Jerzy Cubała, Adam Wlodarczyk, Joanna Szarmach
Multiple Comorbidity Profile of Psychiatric Disorders in Epilepsy. Journal of clinical medicine 10 (18) (2021)
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Włodarczyk, Maria Gałuszko-Węgielnik
Somatic Comorbidities and Cardiovascular Safety in Ketamine Use for Treatment-Resistant Depression. Medicina (Kaunas, Lithuania) 57 (3) (2021)
Joanna Szarmach, Wiesław Jerzy Cubała, Adam Wlodarczyk, Maria Gałuszko-Węgielnik
Metabolic Risk Factors and Cardiovascular Safety in Ketamine Use for Treatment Resistant Depression. Neuropsychiatric disease and treatment 16 (2020)